| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6002487 | Thrombosis Research | 2014 | 7 Pages |
Abstract
The incidence of TEE from IVIg therapy remains high at one in six patients treated. The most remediable factor is a high daily IVIg load. Decreasing the daily IVIg dose together with carefully weighing diuretics therapy and comorbid risk factors may be the keys to saving lives.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Elena RamÃrez, José A. Romero-Garrido, Eduardo López-Granados, Alberto M. Borobia, Tamara Pérez, Nicolás Medrano, Cristina Rueda, Hoi Y. Tong, Alicia Herrero, Jesús FrÃas,